The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy
Abstract
A prodrug forms nanocapsules responsive to tumor GSH/ROS heterogeneity releasing the parent drug SN38 via thiolysis in the presence of GSH (glutathione) or via enhanced hydrolysis due to ROS (reactive oxygen species)-oxidation of the linker, giving rise to high in vitro cytotoxicity and in vivo anticancer therapeutic activity. The nanocapsules are a suitable size for tumor targeting by means of the EPR effect and have a fixed SN38 loading content of 35 wt%, ideal for translational nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emerging applications of stimuli-responsive polymer materials
Stuart, M. A. C., Huck, W. T. S., Genzer, J., Müller, M., Ober, C., Stamm, M., Sukhorukov, G. B., Szleifer, I., Tsukruk, V. V., Urban, M., et al. (2010) · Nature Materials · doi:10.1038/nmat2614 · Cited by 5,707
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Ray, P. D., Huang, B.-W., & Tsuji, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.008 · Cited by 4,373
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Chemistry and biology of reactive oxygen species in signaling or stress responses
Dickinson, B. C., & Chang, C. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.607 · Cited by 1,821
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Tumor heterogeneity: Causes and consequences
Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Cheng, R., Feng, F., Meng, F., Deng, C., Feijen, J., & Zhong, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.030 · Cited by 1,360
Porphyrin-based photosensitizers for use in photodynamic therapy
Sternberg, E. D., Dolphin, D., & Brückner, C. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00015-5 · Cited by 987
Oxidation-responsive polymeric vesicles
Napoli, A., Valentini, M., Tirelli, N., Müller, M., & Hubbell, J. A. (2004) · Nature Materials · doi:10.1038/nmat1081 · Cited by 889
Dual Redox Responsive Assemblies Formed from Diselenide Block Copolymers
Ma, N., Li, Y., Xu, H., Wang, Z., & Zhang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908124g · Cited by 720
Shen, Y., Jin, E., Zhang, B., Murphy, C. J., Sui, M., Zhao, J., Wang, J., Tang, J., Fan, M., Van Kirk, E., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909475m · Cited by 565
Self-citationTherapeutic strategies by modulating oxygen stress in cancer and inflammation
Fang, J., Seki, T., & Maeda, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.005 · Cited by 544
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 540
PEG-SS-PPS: Reduction-Sensitive Disulfide Block Copolymer Vesicles for Intracellular Drug Delivery
Cerritelli, S., Velluto, D., & Hubbell, J. A. (2007) · Biomacromolecules · doi:10.1021/bm070085x · Cited by 443
Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles
Yang, X., Liu, X., Liu, Z., Pu, F., Ren, J., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104797 · Cited by 424
Gao, Y., Chen, Y., Ji, X., He, X., Yin, Q., Zhang, Z., Shi, J., & Li, Y. (2011) · ACS Nano · doi:10.1021/nn2033105 · Cited by 400
Kim, H., Kim, S., Park, C., Lee, H., Park, H. J., & Kim, C. (2010) · Advanced Materials · doi:10.1002/adma.201001417 · Cited by 356
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery
Zhou, Z., Shen, Y., Tang, J., Fan, M., Van Kirk, E. A., Murdoch, W. J., & Radosz, M. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900825 · Cited by 311
Self-citationGriset, A. P., Walpole, J., Liu, R., Gaffey, A., Colson, Y. L., & Grinstaff, M. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807416t · Cited by 305
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
Zhao, Y.-L., Li, Z., Kabehie, S., Botros, Y. Y., Stoddart, J. F., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105371u · Cited by 304
Slatter, J. G., Schaaf, L. J., Sams, J. P., Feenstra, K. L., Johnson, M. G., Bombardt, P. A., Cathcart, K. S., Verburg, M. T., Pearson, L. K., Compton, L. D., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15060-x · Cited by 302
Clinical Pharmacokinetics of Irinotecan
Chabot, G. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733040-00001 · Cited by 282
Challenges in design of translational nanocarriers
Sun, Q., Radosz, M., & Shen, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.042 · Cited by 261
Self-citationKoizumi, F., Kitagawa, M., Negishi, T., Onda, T., Matsumoto, S.-I., Hamaguchi, T., & Matsumura, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1605 · Cited by 256
Austin, C. D., Wen, X., Gazzard, L., Nelson, C., Scheller, R. H., & Scales, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509035102 · Cited by 237
Matsumura, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.008 · Cited by 230
Development and characterization of a novel liposome-based formulation of SN-38
Zhang, J. A., Xuan, T., Parmar, M., Ma, L., Ugwu, S., Ali, S., & Ahmad, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.015 · Cited by 220
Luo, Z., Cai, K., Hu, Y., Li, J., Ding, X., Zhang, B., Xu, D., Yang, W., & Liu, P. (2012) · Advanced Materials · doi:10.1002/adma.201103458 · Cited by 162
Rajan, R., Poniecka, A., Smith, T. L., Yang, Y., Frye, D., Pusztai, L., Fiterman, D. J., Gal‐Gombos, E., Whitman, G., Rouzier, R., et al. (2004) · Cancer · doi:10.1002/cncr.20134 · Cited by 162
Redox metabolism and malignancy
Grek, C. L., & Tew, K. D. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.05.003 · Cited by 160
Tumor heterogeneity and its implication for drug delivery
Denison, T. A., & Bae, Y. H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.014 · Cited by 139
Rivory, L. P., Haaz, M., Canal, P., Lokiec, F. M., Armand, J., & Robert, J. (1997) · PubMed · Cited by 136
Superoxide generation by the respiratory chain of tumor mitochondria
Konstantinov, A. A., Peskin, A. V., Popova, E. Y., Khomutov, G. B., & Ruuge, E. K. (1987) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(87)90206-4 · Cited by 109
Heterogeneity of glutathione content in human ovarian cancer.
Lee, F. Y., Vessey, A. R., Rofstad, E. K., Siemann, D. W., & Sutherland, R. M. (1989) · PubMed · Cited by 92
ElSayed, M. E. H., Hoffman, A. S., & Stayton, P. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.009 · Cited by 88
Mullen, D. G., & Holl, M. M. B. (2011) · Accounts of Chemical Research · doi:10.1021/ar1001389 · Cited by 85
Adams, D. J., & Morgan, L. R. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795029609 · Cited by 63
PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting
Su, W., Wang, H., Wang, S., Liao, Z., Kang, S., Yao, P., Han, L., & Chang, J. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.013 · Cited by 55
Molecular‐targeted nanotherapies in cancer: Enabling treatment specificity
Blanco, E., Hsiao, A., Ruiz‐Esparza, G. U., Landry, M. G., Meric‐Bernstam, F., & Mauro Ferrari, B. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.10.005 · Cited by 51
Overexpression of γ-glutamylcysteine synthetase in human malignant mesothelioma
Järvinen, K., Soini, Y., Kahlos, K., & Kinnula, V. L. (2002) · Human Pathology · doi:10.1053/hupa.2002.126191 · Cited by 36
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Self-citationThe Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
Huang, P., Wang, D., Su, Y., Huang, W., Zhou, Y., Cui, D., Zhu, X., & Yan, D. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505212y · Cited by 716
The role of micelle size in tumor accumulation, penetration, and treatment
Wang, J., Mao, W., Lock, L. L., Tang, J., Sui, M., Sun, W., Cui, H., Xu, D., & Shen, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b02017 · Cited by 635
Self-citation
Metadata
- Authors
- Wang, J., Sun, X., Mao, W., Sun, W., Tang, J., Sui, M., Shen, Y., & Gu, Z.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2013-06-06
- Volume
- 25
- Issue
- 27
- Pages
- 3670-3676
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2038720439
- Cited by
- 395
- References
- 44
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.